This activity is supported by independent medical education grants from Optos North America and Regeneron Pharmaceuticals, Inc.
Expiration Date: 6/1/2020
Diabetic retinopathy (DR) continues to be a leading cause of blindness. However, early diagnosis and prompt treatment with laser and/or intravitreal anti-vascular…go to activity»
This activity is supported by an educational grant from Genentech, Inc.
Expiration Date: 4/11/2020
Anti-VEGF therapy is an important addition to the treatment options for diabetic retinopathy (DR) and is the only medical option that has been granted US Food and Drug…go to activity»
Supported by an educational grant from Allergan Inc.
Expiration Date: 12/17/2019
Despite the critical role of vascular endothelial growth factor (VEGF) inhibitors in managing patients with diabetic macular edema (DME), up to half of patients fail to…go to activity»
This activity is supported by an educational grant from Bausch + Lomb.
Expiration Date: 11/29/2019
Glaucoma is a leading cause of blindness worldwide, with an estimated 70 million people living with this condition. Many individuals with glaucoma remain at risk for…go to activity»
This activity is supported by an educational grant from Shire.
Expiration Date: 11/1/2019
Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to differentially diagnose and is frequently…go to activity»
This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Carl Zeiss Meditec, Inc.; and J & J Vision.
Expiration Date: 9/25/2019
Successful cataract surgery involves a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, which…go to activity»